xAnts

Photys Therapeutics Announces Research Collaboration with Novo Nordisk to Develop Induced Proximity PHICS Technology for Cardiometabolic Diseases

"We are excited to bring together Novo Nordisk's leadership and expertise in cardiometabolic diseases with our unique induced proximity PHICS technology with the goal of advancing a new class of medicines for patients," said Brian Fenton, President a ...Read more